Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002199
What this trial is testing

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Who this might be right for
HIV Infections
Glaxo Wellcome 550
Not applicableLooking for participantsNCT07643948
What this trial is testing

Impacts of HIV Treatment Regimens on Archived Drug Resistance

Who this might be right for
HIV -1 InfectionAntiretroviral TherapyDrug Resistance, Microbial
Chinese University of Hong Kong 420
Early research (Phase 1)Study completedNCT02042248
What this trial is testing

A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004

Who this might be right for
HIV
Cynthia L Gay, MD 6
Not applicableActive Not RecruitingNCT06358885
What this trial is testing

IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention

Who this might be right for
HIV-1-infectionUnhealthy Alcohol Use
University of North Carolina, Chapel Hill 3,234
Not applicableWithdrawnNCT03869671
What this trial is testing

Pre-exposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID)

Who this might be right for
Intravenous Drug Abuse
Boston University
Early research (Phase 1)Study completedNCT03976752
What this trial is testing

Body Compartment Pharmacokinetics of Anti-retroviral Agents That May be Considered for Future On-demand Peri-exposure HIV Prophylaxis Regimens

Who this might be right for
HIV/AIDS
Emory University 41
Not applicableStudy completedNCT05784584
What this trial is testing

Early Anti-Retroviral Treatment in HIV- Infected Children

Who this might be right for
HIV Infections
PENTA Foundation 220
Testing effectiveness (Phase 2)Study completedNCT00534352
What this trial is testing

Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).

Who this might be right for
HIV-1 Infection
Tibotec, Inc 23
Post-approval studies (Phase 4)Study completedNCT00549198
What this trial is testing

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
GlaxoSmithKline 392
Not applicableStudy completedNCT01591252
What this trial is testing

Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)

Who this might be right for
HIVOsteoporosis
University of Alabama at Birmingham 200
Early research (Phase 1)Study completedNCT00944307
What this trial is testing

Effect of Antacids on the Pharmacokinetics of Raltegravir

Who this might be right for
HIV Infections
University of Colorado, Denver 17
Not applicableStudy completedNCT00006064
What this trial is testing

The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children

Who this might be right for
HIV InfectionsHIV Wasting SyndromeLipodystrophy
National Institute of Allergy and Infectious Diseases (NIAID) 100
Post-approval studies (Phase 4)UnknownNCT04435587
What this trial is testing

Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection

Who this might be right for
Asymptomatic InfectionsSARS-CoV2 Infection
Mahidol University 80
Not applicableUnknownNCT05688709
What this trial is testing

Acceptability, Feasibility and Effectiveness of Online Peer Support Group for ART Adherence Among Youth

Who this might be right for
HIV Disease Progression
Infectious Diseases Research Collaboration, Uganda 488
Not applicableStudy completedNCT00540111
What this trial is testing

Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.

Who this might be right for
HypertriglyceridemiaHIV Infections
UPECLIN HC FM Botucatu Unesp 19
Not applicableStudy completedNCT02363387
What this trial is testing

Suppression of HIV 1 RNA in People Living With HIV

Who this might be right for
HIV
Johns Hopkins University 102
Post-approval studies (Phase 4)Study completedNCT01533272
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Not applicableUnknownNCT05996081
What this trial is testing

Adherence Toolkit for Managing Nonadherence to HIV Medications in Indonesia

Who this might be right for
AdultHIV Infections
University of Groningen 400
Not applicableActive Not RecruitingNCT07798167
What this trial is testing

Tuberculosis Sentinel Research Network (TB-SRN)

Who this might be right for
TO ACCESS THE INDIVIDUAL-LEVEL EFFECTS OF HIV AND ANTIRETROVIRAL THERAPY
Centre for Infectious Disease Research in Zambia 374
Not applicableStudy completedNCT00709111
What this trial is testing

Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 34
Next Page